Skip to main content

Author: Paul Govern

Breaking bad with Huntington’s disease

Oct. 5, 2021—Illegal activities are a significant clinical problem in individuals with Huntington’s disease, highlighting the need for improved screening measures and protocols to guide patient management.

Read more


VUMC awarded $31.7 million to harmonize Alzheimer’s research data

Oct. 1, 2021—Vanderbilt University Medical Center has received a $31.7 million federal grant to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias.

Read more


Local family shines in campaign to establish ALS research program

Sep. 23, 2021—Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

Read more


Froehler elected a second time to surgery society board

Sep. 9, 2021—For a second consecutive year, Vanderbilt's Michael Froehler, MD, PhD, has been elected a member of the board of directors of the Society of NeuroInterventional Surgery (SNIS).

Read more


Using billing codes to count cancers

Sep. 2, 2021—The billing codes in electronic health records are useful for counting skin cancers over time — an important metric for cancer risk assessment and prevention.

Read more


Study shows gene-drug interactions are common

Sep. 2, 2021—When a drug or combination of drugs causes different responses in different people, genetic variation is often at play. Pharmacogenomics, through discovery of genetic risk and use of clinical genotyping, aims to reduce trial-and-error approaches to drug prescribing.

Read more


One Hundred Oaks EVS staff at 500 injury-free days and counting

Aug. 26, 2021—At Vanderbilt Health One Hundred Oaks, among the 40 full-time Aramark Corp. employees who work under contract to provide environmental services — EVS, an industry term for health care cleaning services — there has not been an injury requiring medical attention in more than 500 days.

Read more


Wanjalla honored by Doris Duke Foundation

Aug. 12, 2021—Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award.

Read more


Certain drug exposures correlate with reduced COVID severity: study

Aug. 12, 2021—Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.

Read more


Sudden death from deep in the brain?

Aug. 9, 2021—Vanderbilt neurologists found altered excitability in deep brain structures that they note may drive respiratory dysfunction and sudden death in a rare form of epilepsy.

Read more


Facebook campaign quickly nets clinical trial participants

Aug. 5, 2021—The cost and effectiveness of social media as a participant recruitment tool for clinical research is still being evaluated. To better understand its utility, researchers at Vanderbilt University Medical Center used Facebook to mount a short, monthlong pilot campaign in and around Houston attempting to recruit participants for an ongoing smoking cessation study being conducted in that city.

Read more


Ground versus air to transport stroke patients studied

Jul. 29, 2021—For patients in need of acute ischemic stroke treatment, air transport to Vanderbilt University Medical Center is apt to be quicker than ground transport for interhospital transfers of 40 miles or more and for direct-from-scene transfers of 28 miles or more.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more